ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $92,345,000 | +7481.7% | 1,993,194 | +3888.3% | 0.04% | +414.3% |
| Q1 2019 | $1,218,000 | +1223.9% | 49,976 | +377.3% | 0.01% | – |
| Q4 2016 | $92,000 | +119.0% | 10,471 | +4.4% | 0.00% | – |
| Q4 2015 | $42,000 | -12.5% | 10,029 | -3.9% | 0.00% | – |
| Q3 2015 | $48,000 | -36.0% | 10,434 | 0.0% | 0.00% | – |
| Q2 2015 | $75,000 | -6.2% | 10,434 | -3.4% | 0.00% | – |
| Q1 2015 | $80,000 | +116.2% | 10,802 | +5.0% | 0.00% | – |
| Q3 2014 | $37,000 | -21.3% | 10,287 | 0.0% | 0.00% | – |
| Q2 2014 | $47,000 | -2.1% | 10,287 | 0.0% | 0.00% | – |
| Q1 2014 | $48,000 | -7.7% | 10,287 | 0.0% | 0.00% | – |
| Q4 2013 | $52,000 | – | 10,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |